World’s IT Giants Target Japanese Pharmaceutical Companies In Genome Information Sharing
This article was originally published in PharmAsia News
Executive Summary
Amid major Japanese pharmaceutical companies eager to expand into overseas markets a, developing new drugs has been a top priority. In order to speed up new drug development, companies are looking for systems that allow real-time sharing of genome analysis and research information. Several IT giants market new drug development support systems specifically targeting Japanese pharmaceutical companies. British Telecom last month announced it has developed a system supporting Japanese drug makers expanding overseas. American company Cognizant partners with CTC Laboratory Systems, a subsidiary of Itochu Techno-Solutions, and will provide CTC customers with genome analysis services. IBM Japan also plans to expand sales of its system that electronically uploads and shares research notes among pharmaceutical researchers. (Click here for more - Japanese language
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.